期刊文献+

TGFBR2基因多态性与川崎病和冠状动脉损伤相关性的研究 被引量:7

Association of single nucleotide polymorphism in TGFBR2 gene with Kawasaki disease and coronary artery lesions
原文传递
导出
摘要 目的检测儿童转化生长因子β受体2(TGFBR2)基因多态性(rs1495592)的分布情况,并探讨其与川崎病及冠状动脉损伤的相关性。方法应用基因测序技术对35例川崎病患儿(14例并发冠脉损害)的TGFBR2基因多态性(rs1495592)进行研究,另取25例正常同龄儿作对照。结合测序结果分析此多态性与川崎病及冠状动脉损伤的相关性。结果病例组中基因型分布和等位基因频率分布与对照组相比差异均无统计学意义(分别χ2=0.566、0.216,分别P=0.452、0.642)。冠状动脉损害组基因型分布(CC 21.4%,CT+TT 78.6%)与非冠状动脉损害组基因型分布(CC 61.9%,CT+TT 38.1%)差异有统计学意义(χ2=5.546,P=0.019),而两组等位基因频率分布差异无统计学意义(χ2=3.673,P=0.055)。结论儿童中TGFBR2基因多态性(rs1495592)可能与川崎病的发生无相关性,但与川崎病患儿的冠脉损害发生相关。 Objective To examine the single nucleotide polymorphism (SNP) (rs1495592) in transforming growth factor-beta receptor 2 (TGFBR2) gene in children, and to investigate its association with Kawasaki disease (KD) and coronary artery lesions (CALs). Methods Thirty-five KD patients, 14 of whom had CALs (CAL subgroup), were selected as the case group, and 25 healthy age-matched children were selected as the control group. The SNP (rs1495592) in TGFBR2 gene was studied by gene sequencing. The association of SNP (rs1495592) with KD and (CALs) was analyzed based on the sequencing results. Results There were no significant differences in genotype frequency distribution (2,2=0.566, P=0.452) and allele frequency distribution (2'2=0.216, P=0.642) between the two groups. Genotypes in the CAL subgroup included CC (21.4%) and CT+TT (78.6%), while genotypes in the non-CAL subgroup included C C (61.9%) and CT+TT (38.1%). There was significant difference in genotype frequency distribution between the two groups (3(2=5.546, P=-0.019), but without significant difference in allele frequency distribution (22=3.673, P=-0.055). Conclusions The SNP (rs1495592) in TGFBR2 gene may not be associated with development of KD in children, but it is associated with CALs in children with KD.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2013年第9期767-770,共4页 Chinese Journal of Contemporary Pediatrics
基金 天津市卫生局科技基金攻关项目(11KG119)
关键词 转化生长因子β受体2 单核苷酸多态性 川崎病 冠状动脉损伤 儿童 Transforming growth factor-beta receptor 2 Single nucleotide polymorphism Kawasaki disease Coronary artery lesion Child
  • 相关文献

参考文献22

  • 1李瑞燕,李晓辉.川崎病病因学研究进展[J].心血管病学进展,2010,31(4):616-620. 被引量:30
  • 2李焰,王献民,柳颐龄,石坤,杨艳峰,郭永宏.川崎病患儿并发冠状动脉病变的危险因素分析[J].中国当代儿科杂志,2012,14(12):938-941. 被引量:20
  • 3Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGFbeta signaling in vascular fibrosis[J]. Cardiovasc Res, 2007, 74(2): 196-206.
  • 4Clark-Greuel JN, Connolly JM, Soriehillo E, Narula NR, Rapoport HS, Mohler ER 3rd, et al. Transforming growth factor-betal mechanisms in aortic valve calcification: increased alkaline phosphatase and related events[J]. Ann Thorac Surg, 2007, 83(3): 946-953.
  • 5Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling[J]. Nature, 2003, 425(6958): 577-584.
  • 6Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus[J]. Cell, 2003, 113(6): 685-700.
  • 7Wu Y, Li Q, Zhou X, Yu J, Mu Y, Munker S, et al. Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer[J]. PLoS One, 2012, 7(4): e35684.
  • 8周炎,靳光付,蒋国军,王洪敏,谈永飞,丁伟良,王莉娜,陈文森,柯巧,沈靖,徐耀初,沈洪兵.TGFB1和TGFBR2基因多态与胃癌遗传易感性的关系[J].癌症,2007,26(6):581-585. 被引量:5
  • 9Yuan SM, Ma HH, Zhang RS, Jing H. Transforming growth factor-beta signaling pathway in Marfan's syndrome: a preliminary histopathological study[J]. Vasa, 2011, 40(5): 369-374.
  • 10阮瑜,赵晓东.川崎病诊断标准的变迁[J].儿科药学杂志,2012,18(1):1-4. 被引量:17

二级参考文献136

共引文献1309

同被引文献86

  • 1许煊.24例儿童川崎病的早期诊断及冠状动脉扩张高危因素分析[J].暨南大学学报(自然科学与医学版),2005,26(2):255-257. 被引量:2
  • 2胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 3王卫平.儿科学[M].8版.北京:人民卫生出版社,2013,112-114.
  • 4Senzaki H.Long-term outcome of Kawasaki disease[J].Circulation, 2008, 118(25) : 2763-2772.
  • 5Benseler S M, McCrindle B W, Silverman E D, et al.Infections and Kawasaki disease: implications for coronary artery outcome[J].Pediatrics, 2005, 116(6): 760-766.
  • 6Suenage T, Suzuki H, Shibuta S, et al.Deteetion of multiple superantigen genes in stools of patients with kawaski disease[J].J Pediatr, 2009,155(2): 266-270.
  • 7Matsubara K, Fukaya T.The role of superantigens of group A streptococcus and staphylococcus anreus in Kawasaki disease[J].Curr Opin Infect Dis, 2007, 20(3): 298-303.
  • 8Rowett D, Sroeks N, Jaekowski L.Reducing the risk of adverse thrombotic events : the role of asprin and elopidogrel[J].AustrMian Family Physician, 2008, 37(9): 721-726.
  • 9Muta H, Ishii M, Yashiro M, et al.Late intravenous immunoglobulin treatment in patients with Kawasaki disease[J].Pediatrics, 2012, 129(2): 291-297.
  • 10Portman M A, Olson A, Soriano B, et al.Etanerept as adjunctive treatment for acute Kawasaki disease: study design and rationale[J].Am Heart, 2011, 161(3): 494--499.

引证文献7

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部